SEO URLwww.firestrike.ai/deals/rakuten-medical-lotte-biologics-acquisition-2026
acquisitionAnnounced · Jan 14, 2026BiopharmaceuticalsSource · CredibleArticle · Factual
Lotte Biologics acquires Rakuten Medical
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$160M
Target
Rakuten Medical
San Diego, California
Acquirer
Lotte Biologics
Financial Stake
Status
Completed
Lotte Biologics agreed to acquire Rakuten Medical. Reported deal value: $160M. Status: Completed. Sector: Biopharmaceuticals. Target headquarters context: San Diego, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-14. Figures and status may change as filings and press coverage update.
Lotte Biologics has signed a contract manufacturing organization agreement with Rakuten Medical to support the latter production of its photoimmunotherapy-based head and neck cancer treatment, the company said Tuesday
Deal timeline
Announced
Jan 14, 2026 · koreaherald.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biopharmaceuticals with a reported deal value of $160M. Figures and status may change as sources update.
Sources: koreaherald.com · Primary article · FireStrike proprietary index